Why the study?
Are breast cancer survivors at greater risk for CVD-related mortality compared with women without breast cancer?
Are breast cancer survivors at greater risk for CVD-related mortality compared with women without breast cancer?
Breast cancer survivors have an increased risk of CVD-related mortality that manifests around 7 years post-diagnosis, highlighting a critical window for preventive cardiovascular interventions.
May support enhanced long-term CVD monitoring in breast cancer survivors; leaves open whether interventions alter outcomes.
Breast cancer survivors are at greater risk for CVD-related mortality compared with women without breast cancer and this increase in risk is manifested approximately 7 years after diagnosis. Efforts should be made to identify risk factors and interventions that can be employed during this brief window to reduce the excess burden of CVD in this vulnerable population.
No takes yet. Share an insight, caveat, or question.
Bradshaw et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: